284 related articles for article (PubMed ID: 24606888)
21. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
[TBL] [Abstract][Full Text] [Related]
22. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.
Blázquez D; Ramos-Amador JT; Saínz T; Mellado MJ; García-Ascaso M; De José MI; Rojo P; Navarro ML; Muñoz-Fernández MÁ; Saavedra J; Roa MA; Jiménez S; Beceiro J; Prieto L; Hortelano MG; González-Tomé MI
BMC Infect Dis; 2015 Mar; 15():119. PubMed ID: 25880777
[TBL] [Abstract][Full Text] [Related]
23. Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon.
Noumegni SRN; Nansseu JR; Ama VJM; Bigna JJ; Assah FK; Guewo-Fokeng M; Leumi S; Katte JC; Dehayem M; Kengne AP; Sobngwi E
Lipids Health Dis; 2017 Aug; 16(1):148. PubMed ID: 28797289
[TBL] [Abstract][Full Text] [Related]
24. Dyslipidaemia and insulin resistance in vertically HIV-infected children and adolescents.
dos Reis LC; de Carvalho Rondó PH; de Sousa Marques HH; de Andrade SB
Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):197-203. PubMed ID: 21371728
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy.
Padmapriyadarsini C; Ramesh K; Sekar L; Ramachandran G; Reddy D; Narendran G; Sekar S; Chandrasekar C; Anbarasu D; Wanke C; Swaminathan S
Indian J Med Res; 2017 May; 145(5):641-650. PubMed ID: 28948955
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey.
Asiki G; Murphy GA; Baisley K; Nsubuga RN; Karabarinde A; Newton R; Seeley J; Young EH; Kamali A; Sandhu MS
PLoS One; 2015; 10(5):e0126166. PubMed ID: 25974077
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy.
Li X; Song X; Han Y; Qiu Z; Cao W; Li T
BMC Infect Dis; 2023 Sep; 23(1):598. PubMed ID: 37705002
[TBL] [Abstract][Full Text] [Related]
28. Serum lipids and glucose abnormalities in HIV/AIDS patients on antiretroviral therapies.
Salami AK; Akande AA; Olokoba AB
West Afr J Med; 2009 Jan; 28(1):10-5. PubMed ID: 19662738
[TBL] [Abstract][Full Text] [Related]
29. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].
Zhang J; Tang J; Guo X; Dong J; Ren J; Chen X; Gao C; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):230-4. PubMed ID: 26957240
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
[TBL] [Abstract][Full Text] [Related]
32. First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study.
Pefura Yone EW; Betyoumin AF; Kengne AP; Kaze Folefack FJ; Ngogang J
AIDS Res Ther; 2011 Sep; 8():33. PubMed ID: 21943115
[TBL] [Abstract][Full Text] [Related]
33. Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.
Ngo-Matip ME; Pieme CA; Azabji-Kenfack M; Biapa PC; Germaine N; Heike E; Moukette BM; Emmanuel K; Philippe S; Mbofung CM; Ngogang JY
Lipids Health Dis; 2014 Dec; 13():191. PubMed ID: 25496727
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
[TBL] [Abstract][Full Text] [Related]
35. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and determinants of hyperlipidemia in moderate altitude areas of the Yunnan-Kweichow plateau in Southwestern China.
Deng B; Luo T; Huang Y; Shen T; Ma J
High Alt Med Biol; 2012 Mar; 13(1):13-21. PubMed ID: 22429228
[TBL] [Abstract][Full Text] [Related]
37. Lipid profiles and determinants of total cholesterol and hypercholesterolaemia among 25-74 year-old urban and rural citizens of the Yangon Region, Myanmar: a cross-sectional study.
Htet AS; Kjøllesdal MK; Aung WP; Moe Myint AN; Aye WT; Wai MM; Nu TT; Hla EM; Soe PP; Tun NWY; Angela N; Khaing MM; Htoo AK; Tun S; Thitsar P; Lwin T; Wai SS; Aung TT; Thant KA; Aung Po WW; Gauzam ST; Naing TT; Tun TM; Myint KS; Oo KK; Mang NKM; Naing SM; Zaw KK; Bjertness MB; Sherpa LY; Oo WM; Stigum H; Bjertness E
BMJ Open; 2017 Nov; 7(11):e017465. PubMed ID: 29146640
[TBL] [Abstract][Full Text] [Related]
38. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
39. Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.
Patroni A; Torti C; Tomasoni L; Quiros Roldan E; Bertelli D; Puoti M; Cadeo GP; Sleiman I; Tinelli C; Carosi G; Castelli F
HIV Clin Trials; 2002; 3(6):451-61. PubMed ID: 12501128
[TBL] [Abstract][Full Text] [Related]
40. Impact of HIV infection and HAART on serum lipids in men.
Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
